Want to know what's happening next in healthcare?

MedCityNews is the leading online news source for the business of innovation in healthcare.

“Follow MedCity News if you want to know who is doing what in healthcare innovation - and whether it's working or not.”

Chris Seper, CEO & Founder, MedCityNews.com

Sign up for our daily newsletter

California device startup treating abnormal uterine bleeding raises $20M

2:25 pm by | 1 Comments

California device startup and women’s health firm Minerva Surgical has recently raised $20 million, according to a regulatory filing.

The Cupertino-based company has developed an endometrial ablation system utilizing RF Argon Plasma Energy contained in a balloon to treat heavy menstrual bleeding.

Based on a search of the U.S. Securities and Exchange Commission’s Edgar database, the company has been steadily raising money since 2008 and has raised more than $55 million. David M. Clapper, a 16-year veteran of Johnson & Johnson, is Minerva Surgical’s CEO.


Venture capital firm New Enterprise Associates and Vivo Ventures are investors in the company, although it is not known whether they invested in this round of funding.

[Photo Credit: Pile of Money from Big Stock Photo]



Copyright 2014 MedCity News. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Arundhati Parmar

By Arundhati Parmar

Arundhati Parmar is the Medical Devices Reporter at MedCity News. She has covered medical technology since 2008 and specialized in business journalism since 2001. Parmar has three degrees from three continents - a Bachelor of Arts in English from Jadavpur University, Kolkata, India; a Masters in English Literature from the University of Sydney, Australia and a Masters in Journalism from Northwestern University in Chicago. She has sworn never to enter a classroom again.
More posts by Author


Based upon a bing search of the U.S. Securities and Exchange Commission’s Edgar database, the business happens to be steadily raising funds since 2008 and also brought up over $55 billion. David M. Clapper, a 16-year seasoned of Johnson & Johnson, is Minerva Surgical’s CEO